Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Husson

Showing results (121-130 of 132) with videos related to

Pageof 14
Sort By:
The Prostate|January 1, 1983
New approach in the treatment of prostate cancer: complete instead of partial withdrawal of androgensF Labrie, A Dupont, A Belanger, et al.
Alcohol (Fayetteville, N.Y.)|March 4, 1999
Does the short variant of the serotonin transporter linked polymorphic region constitute a marker of alcohol dependence?S Hammoumi, A Payen, J D Favre, et al.
The New England Journal of Medicine|August 17, 1989
Prevention of the transient adverse effects of a gonadotropin-releasing hormone analogue (buserelin) in metastatic prostatic carcinoma by administration of an antiandrogen (nilutamide)J M Kuhn, T Billebaud, H Navratil, et al.
Maturitas|July 1, 1980
Effects of RU16117, an orally active weak oestrogenic compound, in postmenopausal womenN Faure, F Labrie, G Olivier, et al.
ACS Applied Materials & Interfaces|August 19, 2025
Halloysite/polyaniline Nanocomposites for Enhanced Actinide SorptionValery N Bliznyuk, Yuriy V Noskov, Kamila Karniłowicz, et al.
Journal of Steroid Biochemistry|April 1, 1984
RU 16117, an orally active estriol-like weak estrogenJ P Raynaud, G Azadian-Boulanger, M M Bouton, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 2, 2019
Neoproterozoic glacial origin of the Great UnconformityC Brenhin Keller, Jon M Husson, Ross N Mitchell, et al.
The Journal of Nutrition, Health & Aging|August 13, 2013
Guidance synthesis. Medical research for and with older people in Europe: proposed ethical guidance for good clinical practice: ethical considerationsL Diener, L Hugonot-Diener, S Alvino, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|January 1, 1982
New hormonal therapy in prostatic carcinoma: combined treatment with an LHRH agonist and an antiandrogenF Labrie, A Dupont, A Belanger, et al.
Journal of Steroid Biochemistry|July 1, 1983
New hormonal treatment in cancer of the prostate: combined administration of an LHRH agonist and an antiandrogenF Labrie, A Dupont, A Belanger, et al.
Pageof 14

Showing results (121-130 of 132) with videos related to

Sort By:
Pageof 14
The Prostate|January 1, 1983
New approach in the treatment of prostate cancer: complete instead of partial withdrawal of androgensF Labrie, A Dupont, A Belanger, et al.
Alcohol (Fayetteville, N.Y.)|March 4, 1999
Does the short variant of the serotonin transporter linked polymorphic region constitute a marker of alcohol dependence?S Hammoumi, A Payen, J D Favre, et al.
The New England Journal of Medicine|August 17, 1989
Prevention of the transient adverse effects of a gonadotropin-releasing hormone analogue (buserelin) in metastatic prostatic carcinoma by administration of an antiandrogen (nilutamide)J M Kuhn, T Billebaud, H Navratil, et al.
Maturitas|July 1, 1980
Effects of RU16117, an orally active weak oestrogenic compound, in postmenopausal womenN Faure, F Labrie, G Olivier, et al.
ACS Applied Materials & Interfaces|August 19, 2025
Halloysite/polyaniline Nanocomposites for Enhanced Actinide SorptionValery N Bliznyuk, Yuriy V Noskov, Kamila Karniłowicz, et al.
Journal of Steroid Biochemistry|April 1, 1984
RU 16117, an orally active estriol-like weak estrogenJ P Raynaud, G Azadian-Boulanger, M M Bouton, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 2, 2019
Neoproterozoic glacial origin of the Great UnconformityC Brenhin Keller, Jon M Husson, Ross N Mitchell, et al.
The Journal of Nutrition, Health & Aging|August 13, 2013
Guidance synthesis. Medical research for and with older people in Europe: proposed ethical guidance for good clinical practice: ethical considerationsL Diener, L Hugonot-Diener, S Alvino, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|January 1, 1982
New hormonal therapy in prostatic carcinoma: combined treatment with an LHRH agonist and an antiandrogenF Labrie, A Dupont, A Belanger, et al.
Journal of Steroid Biochemistry|July 1, 1983
New hormonal treatment in cancer of the prostate: combined administration of an LHRH agonist and an antiandrogenF Labrie, A Dupont, A Belanger, et al.
Pageof 14